MiMedx Group Inc reports results for the quarter ended in September 30 - Earnings Summary

MiMedx

31/10/2024 02:41

* MiMedx Group Inc  MDXG.OQ  reported quarterly adjusted
earnings
of 5 cents​​ per share for the quarter ended September 30, lower
than the same quarter last year, when the company reported EPS
of 6 cents.  The mean expectation of five analysts for the
quarter was for earnings of 4 cents per share. Wall Street
expected results to range from 4 cents to 5 cents per share.
    * Revenue rose 2.9% to $84.06 million from a year ago;
analysts
expected $82.70 million. 
    * MiMedx Group Inc's reported EPS for the quarter was 5
cents​.
    * The company reported quarterly net income of $7.88
million.
    * MiMedx Group Inc shares had fallen by 1.7% this
quarter and
lost 33.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 28.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MiMedx Group Inc
is $12.00 
This summary was machine generated from LSEG data October 31 at
02:40 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.04           0.05           Beat
 Jun. 30 2024      0.08           0.12           Beat
 Mar. 31 2024      0.05           0.07           Beat
 Dec. 31 2023      0.07           0.32           Beat